Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Innate Pharma SA (IPHA)GlobeNewsWire • 12/09/20
LOOMING DEC. 22 DEADLINE Pawar Law Group Announces a Securities Class Action Lawsuit Against Innate Pharma S.A.GlobeNewsWire • 12/09/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Innate Pharma S.A. – IPHAGlobeNewsWire • 12/08/20
Rosen, A Leading and Longstanding Law Firm, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action First Filed by Firm; Encourages Investors with Losses Exceeding $100K to Contact Firm - IPHANewsfile Corp • 12/07/20
Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual CongressGlobeNewsWire • 12/03/20
ROSEN, A LEADING LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact the Firm - IPHAPRNewsWire • 12/02/20
UPCOMING DEC. 22 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Innate Pharma S.A.GlobeNewsWire • 11/26/20
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses Exceeding $100K to Contact Firm - IPHANewsfile Corp • 11/23/20
Innate Pharma reports third quarter 2020 financial results and business updateGlobeNewsWire • 11/17/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses Exceeding $100K to Contact Firm - IPHAPRNewsWire • 11/14/20
Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary SyndromeGlobeNewsWire • 11/13/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm - IPHANewsfile Corp • 11/09/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm - IPHANewsfile Corp • 11/07/20
IPHA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Innate Pharma S.A. Investors of Class Action and Lead Plaintiff Deadline: December 22, 2020Newsfile Corp • 11/06/20
IPHA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Innate Pharma S.A. Shareholders of Class Action and Lead Plaintiff Deadline: December 22, 2020Business Wire • 11/02/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important Deadline in First Filed Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - IPHAPRNewsWire • 10/31/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Innate Pharma SA (IPHA) InvestorsBusiness Wire • 10/30/20
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Innate Pharma SA (IPHA) InvestorsBusiness Wire • 10/30/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Innate Pharma SA (IPHA) InvestorsBusiness Wire • 10/30/20
The Law Offices of Frank R. Cruz Announces Investigation of Innate Pharma SA (IPHA) on Behalf of InvestorsBusiness Wire • 10/29/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Innate Pharma SA (IPHA) on Behalf of InvestorsBusiness Wire • 10/29/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Innate Pharma SA (IPHA) on Behalf of InvestorsBusiness Wire • 10/29/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important Deadline in Securities Class Action – IPHABusiness Wire • 10/28/20
Shareholder Alert: Robbins LLP Announces It Is Investigating Innate Pharma S.A. (IPHA) for Misleading ShareholdersPRNewsWire • 10/27/20
